Upcoming event
22nd Meeting of the EAU Robotic Urology Section
Back

Tags

Article of the Month, ASCO GU22, ASCO21, AUA21, Cabozantinib, Carcinoma, Chronic kidney disease, Cryosurgery, EAU, EAU21, EAU22, EMUC21, EMUC22, ERUS22, ESMO21, Frail patient​, Glomerular filtration rate, Guidelines, IMDC risk model, Kidney cancer, Laparoscopy, Lymph node metastases, Lymph nodes, Metastasectomy, Mortality, Neoplasm metastasis, Neoplasm recurrence, Nephrectomy, Nephron-sparing surgery, Nivolumab, Overall survival, Partial nephrectomy, Prognostication, Radical nephrectomy, Radical surgery, RCC, Renal cancer, Renal cell, Renal cell carcinoma, Renal Cell Carcinoma guidelines, Renal cryoablation, Renal function, Renal Transplantation, Renorrhaphy, Robotic, Robotic prostatectomy, Robotic surgery, Survival outcome, Suture, Targeted therapies, Treatment response, Urological surgery, UROonco24, UROwebinar, Webinar
Show all

Exploratory analysis from NEOAVAX, a neoadjuvant trial of avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy

ASCO25, May 2025

View

Hypoxia-inducible factor-2α (HIF-2α) inhibitor belzutifan in von Hippel-Lindau (VHL) disease–associated neoplasms: 5-year follow-up of the phase 2 LITESPARK-004 study

ASCO25, May 2025

View

Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRa

Annals of Oncology, April 2025

View

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

Nature, February 2025

View

Advancing non-invasive renal cell carcinoma diagnostics: Proteomic insights from urinary extracellular vesicles

EAU25, March 2025

View

The role of circulating kidney injury molecule-1 (KIM-1) in metastatic renal cell carcinoma (mRCC): A biomarker analysis of Tide-A, a phase 2 study of first-line avelumab (ave) plus intermittent axitinib (axi)

EAU25, March 2025

View

Intratumoral microbiota composition regulates tumor progression in clear cell renal cell carcinoma

EAU25, March 2025

View

Validation of the UICC 8th T staging system and potential refinement with renal parenchymal infiltration or micronodular spread in clear cell renal cell carcinoma

EAU25, March 2025

View

Preoperative prediction of adherent perirenal fat based on CT radiomics combined with deep learning: A prospective, multicenter study

EAU25, March 2025

View

Top 10 tips in robotic tumour thrombectomy: Experience from high volume renal cancer centre

View
webcasts

Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Final follow-up results from the CheckMate 9ER trial

ASCO GU25, February 2025

View

Cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC): Final results of COSMIC-313

ASCO GU25, February 2025

View
Next